ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment

Eugen Widmeier; Seyoung Yu; Anish Nag; Youn Wook Chung; Makiko Nakayama; Lucía Fernández-del-Río; Hannah Hugo; David Schapiro; Florian Buerger; Won-Il Choi; Martin Helmstädter; Jae-woo Kim; Ji-Hwan Ryu; Min Goo Lee; Catherine F. Clarke; Friedhelm Hildebrandt; Heon Yung Gee

doi:10.1681/ASN.2019070756

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Visual Abstract

Significance Statement

ADCK4 mutations generally manifest as steroid-resistant nephrotic syndrome, and cause coenzyme Q₁₀ (CoQ₁₀) deficiency. However, ADCK4’s function remains obscure. Using mouse and cell models, the authors demonstrated that podocyte-specific Adck4 deletion in mice significantly reduced survival and caused severe FSGS, effects that were prevented by treatment with 2,4-dihydroxybenzoic acid (2,4-diHB), a CoQ₁₀ precursor analogue. ADCK4-knockout podocytes exhibited a significantly reduced CoQ₁₀ level and defects in mitochondrial function that were rescued by 2,4-diHB treatment, thus these phenotypes were attributed to decreased CoQ₁₀ levels. The authors also found that ADCK4 interacted with mitochondrial proteins, including COQ5, and that ADCK4 knockout decreased COQ complex levels. These findings reveal that ADCK4 is required for CoQ₁₀ biosynthesis and mitochondrial function in podocytes, and suggests a treatment strategy for nephrotic syndrome caused by ADCK4 mutations.

Abstract

Background Mutations in ADCK4 (aarF domain containing kinase 4) generally manifest as steroid-resistant nephrotic syndrome and induce coenzyme Q₁₀ (CoQ₁₀) deficiency. However, the molecular mechanisms underlying steroid-resistant nephrotic syndrome resulting from ADCK4 mutations are not well understood, largely because the function of ADCK4 remains unknown.

Methods To elucidate the ADCK4’s function in podocytes, we generated a podocyte-specific, Adck4-knockout mouse model and a human podocyte cell line featuring knockout of ADCK4. These knockout mice and podocytes were then treated with 2,4-dihydroxybenzoic acid (2,4-diHB), a CoQ₁₀ precursor analogue, or with a vehicle only. We also performed proteomic mass spectrometry analysis to further elucidate ADCK4’s function.

Results Absence of Adck4 in mouse podocytes caused FSGS and albuminuria, recapitulating features of nephrotic syndrome caused by ADCK4 mutations. In vitro studies revealed that ADCK4-knockout podocytes had significantly reduced CoQ₁₀ concentration, respiratory chain activity, and mitochondrial potential, and subsequently displayed an increase in the number of dysmorphic mitochondria. However, treatment of 3-month-old knockout mice or ADCK4-knockout cells with 2,4-diHB prevented the development of renal dysfunction and reversed mitochondrial dysfunction in podocytes. Moreover, ADCK4 interacted with mitochondrial proteins such as COQ5, as well as cytoplasmic proteins such as myosin and heat shock proteins. Thus, ADCK4 knockout decreased the COQ complex level, but overexpression of ADCK4 in ADCK4-knockout podocytes transfected with wild-type ADCK4 rescued the COQ5 level.

Conclusions Our study shows that ADCK4 is required for CoQ₁₀ biosynthesis and mitochondrial function in podocytes, and suggests that ADCK4 in podocytes stabilizes proteins in complex Q in podocytes. Our study also suggests a potential treatment strategy for nephrotic syndrome resulting from ADCK4 mutations.

View Full Text

Log in through your institution

Purchase access

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$27.00

When you create an account, you will be asked for your name, email address and other information. Just like commercial web sites, we do need details from you in order to complete your purchase of an article. Select the "Create an Account" link to create your account.

You will then be asked to register a user name, email address and you will need to create a password that is at least eight characters in length. As you move through the registration page, you will have to verify you are a person by completing a Captcha request. Lastly, your first and last name will be required.

Once your information is successfully saved, the system will redisplay the home page of the journal. From there, navigate back to the article to purchase. Select the article and at the bottom of the page, use the credentials you just created to login. The article will be added to your shopping cart. You can continue to navigate across JASN and CJASN adding to your cart from both journals. When you are ready to complete your purchse, select the Shopping Cart from the upper right hand corner of the page and follow the onscreen instructions.